NasdaqGM - Nasdaq Real Time Price USD
ADMA Biologics, Inc. (ADMA)
19.98
-1.22
(-5.75%)
At close: May 9 at 4:00:01 PM EDT
20.00
+0.02
+(0.10%)
After hours: May 9 at 7:59:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 501,367 | 13 |
| Sales | 105,967 | 4 |
| Net Shares Purchased (Sold) | 395,400 | 17 |
| Total Insider Shares Held | 6.15M | -- |
| % Net Shares Purchased (Sold) | 6.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GROSSMAN ADAM S Chief Executive Officer | Conversion of Exercise of derivative security at price 5.40 per share. | Direct | 81,000 | Apr 15, 2025 |
| GROSSMAN ADAM S Chief Executive Officer | Sale at price 21.46 per share. | Direct | 450,660 | Apr 15, 2025 |
| GROSSMAN ADAM S Chief Executive Officer | Conversion of Exercise of derivative security at price 5.40 per share. | Direct | 81,000 | Mar 19, 2025 |
| GROSSMAN ADAM S Chief Executive Officer | Sale at price 18.92 per share. | Direct | 397,320 | Mar 19, 2025 |
| GROSSMAN JERROLD B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| GROSSMAN ADAM S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| GUIHEEN LAWRENCE P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| FINGER ALISON CECILY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| KWON YOUNG T. PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| ELMS STEVEN A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| SALAS EDUARDO RENE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| KESTENBERG-MESSINA KAITLIN M. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| TADE BRAD L Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
| KESTENBERG-MESSINA KAITLIN M. Chief Operating Officer | Conversion of Exercise of derivative security at price 10.80 per share. | Direct | 54,000 | Jan 30, 2025 |
| ELMS STEVEN A Director | Conversion of Exercise of derivative security at price 10.80 per share. | Indirect | 97,200 | Nov 27, 2024 |
| GROSSMAN ADAM S Chief Executive Officer | Sale at price 21.10 per share. | Direct | 1,033,204 | Nov 22, 2024 |
| TADE BRAD L Chief Financial Officer | Sale at price 21.15 per share. | Direct | 317,250 | Nov 22, 2024 |
| GUIHEEN LAWRENCE P Director | Conversion of Exercise of derivative security at price 10.80 per share. | Direct | 97,200 | Sep 9, 2024 |
| GUIHEEN LAWRENCE P Director | Sale at price 18.47 per share. | Direct | 166,189 | Sep 9, 2024 |
| KESTENBERG-MESSINA KAITLIN M. Officer | Conversion of Exercise of derivative security at price 2.35 - 5.94 per share. | Direct | 93,526 | Aug 30, 2024 |
| KESTENBERG-MESSINA KAITLIN M. Officer | Sale at price 16.90 per share. | Direct | 408,050 | Aug 30, 2024 |
| GROSSMAN JERROLD B Director | Conversion of Exercise of derivative security at price 3.66 - 10.80 per share. | Direct | 585,871 | Aug 29, 2024 |
| GROSSMAN JERROLD B Director | Sale at price 17.27 per share. | Direct | 2,363,932 | Aug 29, 2024 |
| GROSSMAN ADAM S Chief Executive Officer | Conversion of Exercise of derivative security at price 2.92 - 10.80 per share. | Direct | 2,903,192 | Aug 27, 2024 |
| GROSSMAN ADAM S Chief Executive Officer | Sale at price 17.29 - 17.69 per share. | Direct | 10,923,987 | Aug 27, 2024 |
| KWON YOUNG T. PH.D. Director | Sale at price 18.26 per share. | Direct | 1,095,600 | Aug 23, 2024 |
| TADE BRAD L Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 24, 2024 |
| GROSSMAN ADAM S Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 14, 2024 |
| GROSSMAN ADAM S Chief Executive Officer | Sale at price 10.72 per share. | Direct | 1,071,980 | Jun 14, 2024 |
| KESTENBERG-MESSINA KAITLIN M. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| ELMS STEVEN A Director | Sale at price 6.01 - 6.08 per share. | Indirect | 2,803,741 | Mar 19, 2024 |
| ELMS STEVEN A Director | Sale at price 6.01 - 6.21 per share. | Indirect | 6,339,418 | Mar 15, 2024 |
| GROSSMAN JERROLD B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
| GROSSMAN ADAM S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
| FONG BRYANT E. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
| GUIHEEN LAWRENCE P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
| FINGER ALISON CECILY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
| KWON YOUNG T. PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
| ELMS STEVEN A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
| GROSSMAN JERROLD B Director | Purchase at price 3.71 per share. | Direct | 482,144 | Aug 30, 2023 |
| KWON YOUNG T. PH.D. Director | Purchase at price 3.90 per share. | Direct | 97,500 | Aug 24, 2023 |
| FONG BRYANT E. Director | Sale at price 3.87 per share. | Indirect | 5,544,737 | Aug 22, 2023 |
| GROSSMAN ADAM S Chief Executive Officer | Sale at price 4.15 per share. | Direct | 1,038,350 | Aug 18, 2023 |
| LENZ BRIAN Chief Financial Officer | Sale at price 4.45 - 4.60 per share. | Direct | 1,766,130 | Aug 16, 2023 |
| GROSSMAN ADAM S Chief Executive Officer | Sale at price 4.38 - 4.54 per share. | Direct | 2,318,972 | Aug 16, 2023 |
| LENZ BRIAN Chief Financial Officer | Conversion of Exercise of derivative security at price 1.67 - 3.71 per share. | Direct | 2,514,363 | Aug 15, 2023 |
| GROSSMAN ADAM S Chief Executive Officer | Conversion of Exercise of derivative security at price 1.67 - 3.71 per share. | Direct | 6,536,448 | Aug 15, 2023 |
Related Tickers
TGTX TG Therapeutics, Inc.
33.64
-0.65%
HALO Halozyme Therapeutics, Inc.
65.87
-2.75%
ARGX argenx SE
549.65
-3.42%
PTCT PTC Therapeutics, Inc.
44.23
+4.05%
CPRX Catalyst Pharmaceuticals, Inc.
23.37
+2.68%
SMMT Summit Therapeutics Inc.
23.96
-2.80%
SRPT Sarepta Therapeutics, Inc.
36.27
-0.68%
VRNA Verona Pharma plc
63.32
-4.44%
IOVA Iovance Biotherapeutics, Inc.
1.7500
-44.79%
CORT Corcept Therapeutics Incorporated
70.23
-1.61%